Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan · Delayed Price · Currency is TWD 102.50
-2.00 (-1.91%)
Aug 19, 2026, 1:30 PM CST
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 162.54 billion as of August 18, 2026. Its market cap has decreased by -34.30% in one year.
Market Cap
162.54B
Enterprise Value
158.60B
Revenue
29.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
102.50
ChartMarket Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 162.54B, an increase of 1,942.36%. That is a compound annual growth rate of 128.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 162.54B | -32.35% |
| Dec 31, 2025 | 240.25B | 154.60% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
| Dec 26, 2022 | 7.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lin BioScience | 75.54B |
| Pell Bio-Med Technology | 68.36B |
| CHO Pharma | 24.18B |
| Oneness Biotech | 22.48B |
| Sunmax Biotechnology | 21.00B |
| Medigen Vaccine Biologics | 16.93B |
| TaiMed Biologics | 16.83B |
| Ever Supreme Bio Technology | 14.96B |